Investing in Health Care: 3 Innovative New Drugs to Watch
Posted in Investments by Kevin | Tags: biotechnology, cancer, drug, drugs, health care, Investments, malarial drug, nanotechnology, novartis, pharmaceuticalsAccording to analysts, about 1 in 13 successful drugs is a “blockbuster.” Blockbuster drugs net over a billion in revenue and keep pharmaceutical companies profitable. Many new drugs can fail, get out-competed by other drugs, or never hit full stride, costing companies hundreds of millions of dollars lost to research, marketing, and approval.
Recently, I came across a few up and coming drugs and wanted to shed some light on whether investing in their respective manufacturing companies is a good idea or not.
1) Novartis- Malarial Drug – “spiroindolones”
Subscribe for E-mail Updates
Navigate
New on SmarterSpend
- How Hire a Contractor for Less Without Sacrificing Quality
- Top 5 Craigslist Scams to Avoid
- 8 Companies Facing Bankruptcy in 2011
- The Ultimate Personal Finance Blog Rankings from MoneyCrashers!
- Investing in Health Care: 3 Innovative New Drugs to Watch
Hot Topix
department stores
Careers
Electronics
Biomedical Engineers
shopping
car
loans
cheap
online
Veterinarians
companies
lifestyle
Economy
automobile
Utilities
Investments
wealth
budget
bill
Cable
credit
Dates
future
gold
business
Education
stocks
Insurance
Restaraunts
sales
promotions
Groceries
fast food
el pollo loco
student
Living Expenses
college
coupons
career
Finance
country
save
house
free
food
energy
invest
Clothing
camera
save money
department store
World Affairs
home
Spending
Dental Hygienist
Corporate
sale
Physician Assistants
jobs
2010
household
Health
credit card
Personal Finance
Electricity
real estate
world
dining
discounts
money